SCHEMBL4937386

SCHEMBL4937386

COc1cc2c(Sc3ccccc3)c(C(=O)Nc3nn[nH]n3)n(C)c2cc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PABPC1 P11940 1/20 0.47
EIF4H Q15056 1/20 0.47
EDNRB P24530 4/20 0.45
EDNRA P25101 4/20 0.45
APP P05067 1/20 0.41
ME2 P23368 1/20 0.40
ME1 P48163 1/20 0.40
ME3 Q16798 1/20 0.40
MPO P05164 1/20 0.39
CYSLTR1 Q9Y271 1/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
TUBB4A P04350 2/20 0.39
TUBB P07437 2/20 0.39
TUBA3C P0DPH7 2/20 0.39
TUBA1B P68363 2/20 0.39
TUBA4A P68366 2/20 0.39
TUBB4B P68371 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4764429 0.79 EDNRB (0.59) PABPC1EIF4HEDNRBEDNRAALDH1A1
SCHEMBL5889114 0.74 TUBB4A (0.59) PABPC1EIF4HEDNRBEDNRAALDH1A1
SCHEMBL4938247 0.67 TUBB4A (0.43) MPOCYSLTR1KMT2ATUBB4ATUBB
SCHEMBL15659459 0.66 MPO (0.61) EDNRAME2ME1ME3MPO
SCHEMBL9536999 0.66 KDM4E (0.43) PABPC1EIF4HEDNRBEDNRAALDH1A1
SCHEMBL5744199 0.63 MPO (0.57) EDNRAAPPME2ME1ME3
SCHEMBL6817003 0.62 EDNRA (0.41) EDNRBEDNRAMPOCYSLTR1ALDH1A1
SCHEMBL9537134 0.61 KDM4E (0.58) PABPC1EIF4HEDNRBEDNRAALDH1A1
SCHEMBL21465511 0.60 MEN1 (0.67) PABPC1EIF4HEDNRBEDNRAALDH1A1
SCHEMBL4762798 0.60 TUBB4A (0.74) MEN1KMT2ATUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287469-A1 Phosphoinositide 3-Kinase Inhibitors for Inhibiting Leukocyte Accumulation DIACOVO THOMAS G 2008-11-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287469-A1 Phosphoinositide 3-Kinase Inhibitors for Inhibiting Leukocyte Accumulation PI4KB, PIK3CA, PI4KA PABPC1 2102/4885EIF4H 3434/4885EDNRB 1628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.